术中放疗对边缘阳性局部晚期直肠癌的影响:国家癌症数据库的倾向匹配分析。

IF 1.9 3区 医学 Q3 ONCOLOGY
Metincan Erkaya, Salih Karahan, Mustafa Oruc, Sudha R Amarnath, Jacob A Miller, Ali Alipouriani, Brogan Catalano, Scott Steele, Emre Gorgun
{"title":"术中放疗对边缘阳性局部晚期直肠癌的影响:国家癌症数据库的倾向匹配分析。","authors":"Metincan Erkaya, Salih Karahan, Mustafa Oruc, Sudha R Amarnath, Jacob A Miller, Ali Alipouriani, Brogan Catalano, Scott Steele, Emre Gorgun","doi":"10.1002/jso.70102","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Intraoperative radiotherapy (IORT) is utilized as an adjunctive treatment in advanced rectal cancer, particularly in cases with threatened surgical margins. Although IORT has shown benefits in enhancing local tumor control, its impact on overall survival (OS) remains unclear. This study assesses the effect of IORT on survival outcomes using a large cohort from the National Cancer Database (NCDB) and examines factors influencing its application in clinical practice across the United States.</p><p><strong>Methods: </strong>The National Cancer Database was retrospectively reviewed (2006-2019) to identify patients with pathological T3-T4, M0 rectal cancer who underwent surgery following neoadjuvant chemotherapy. Patients with microscopically residual margin-positive were included and categorized into two groups: those who received neoadjuvant radiotherapy (RT) and those treated with intraoperative radiotherapy (IORT) combined with adjuvant/neoadjuvant RT. Groups were propensity score-matched (1:4) to balance baseline characteristics. The primary outcome was 5-year overall survival (OS), assessed using Kaplan-Meier analysis and Cox proportional hazards modeling.</p><p><strong>Results: </strong>Among 1,788 patients with margin-positive rectal cancer, IORT was administered to 119 patients (6.7%) while 1,669 patients (93.3%) received neoadjuvant RT. Patients receiving IORT were younger, more likely to have private insurance, more frequently treated at academic/research programs, and more commonly underwent pelvic exenteration and Multiagent chemotherapy. After propensity score matching, 119 IORT patients were compared with 476 neoadjuvant RT patients. IORT was associated with lower mortality in univariate analysis (HR: 0.63; p < 0.001); however, this benefit was attenuated after adjusting for confounders (HR: 0.84; p = 0.07). The 5-year overall survival rates were 58.4% for IORT versus 54.9% for neoadjuvant RT alone (p = 0.18).</p><p><strong>Conclusion: </strong>This nationwide analysis suggests that adding IORT to treatment does not significantly improve overall survival in margin-positive rectal cancer patients. However, due to heterogeneity in patient selection and dosing, further prospective trials are warranted to clarify its clinical role.</p>","PeriodicalId":17111,"journal":{"name":"Journal of Surgical Oncology","volume":" ","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Impact of Intraoperative Radiotherapy on Margin Positive Locally Advanced Rectal Cancer: A Propensity-Matched Analysis of The National Cancer Database.\",\"authors\":\"Metincan Erkaya, Salih Karahan, Mustafa Oruc, Sudha R Amarnath, Jacob A Miller, Ali Alipouriani, Brogan Catalano, Scott Steele, Emre Gorgun\",\"doi\":\"10.1002/jso.70102\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>Intraoperative radiotherapy (IORT) is utilized as an adjunctive treatment in advanced rectal cancer, particularly in cases with threatened surgical margins. Although IORT has shown benefits in enhancing local tumor control, its impact on overall survival (OS) remains unclear. This study assesses the effect of IORT on survival outcomes using a large cohort from the National Cancer Database (NCDB) and examines factors influencing its application in clinical practice across the United States.</p><p><strong>Methods: </strong>The National Cancer Database was retrospectively reviewed (2006-2019) to identify patients with pathological T3-T4, M0 rectal cancer who underwent surgery following neoadjuvant chemotherapy. Patients with microscopically residual margin-positive were included and categorized into two groups: those who received neoadjuvant radiotherapy (RT) and those treated with intraoperative radiotherapy (IORT) combined with adjuvant/neoadjuvant RT. Groups were propensity score-matched (1:4) to balance baseline characteristics. The primary outcome was 5-year overall survival (OS), assessed using Kaplan-Meier analysis and Cox proportional hazards modeling.</p><p><strong>Results: </strong>Among 1,788 patients with margin-positive rectal cancer, IORT was administered to 119 patients (6.7%) while 1,669 patients (93.3%) received neoadjuvant RT. Patients receiving IORT were younger, more likely to have private insurance, more frequently treated at academic/research programs, and more commonly underwent pelvic exenteration and Multiagent chemotherapy. After propensity score matching, 119 IORT patients were compared with 476 neoadjuvant RT patients. IORT was associated with lower mortality in univariate analysis (HR: 0.63; p < 0.001); however, this benefit was attenuated after adjusting for confounders (HR: 0.84; p = 0.07). The 5-year overall survival rates were 58.4% for IORT versus 54.9% for neoadjuvant RT alone (p = 0.18).</p><p><strong>Conclusion: </strong>This nationwide analysis suggests that adding IORT to treatment does not significantly improve overall survival in margin-positive rectal cancer patients. However, due to heterogeneity in patient selection and dosing, further prospective trials are warranted to clarify its clinical role.</p>\",\"PeriodicalId\":17111,\"journal\":{\"name\":\"Journal of Surgical Oncology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2025-09-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Surgical Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/jso.70102\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Surgical Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/jso.70102","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:术中放疗(IORT)被用作晚期直肠癌的辅助治疗,特别是在手术边缘受到威胁的情况下。尽管IORT已显示出增强局部肿瘤控制的益处,但其对总生存期(OS)的影响尚不清楚。本研究使用来自国家癌症数据库(NCDB)的大型队列来评估IORT对生存结果的影响,并检查影响其在美国临床实践中应用的因素。方法:回顾性分析国家癌症数据库(2006-2019),确定新辅助化疗后手术的病理性T3-T4, M0直肠癌患者。纳入显微镜下残余边缘阳性患者,并将其分为两组:接受新辅助放疗(RT)的患者和接受术中放疗(IORT)联合辅助/新辅助放疗的患者。各组倾向评分匹配(1:4)以平衡基线特征。主要终点为5年总生存期(OS),采用Kaplan-Meier分析和Cox比例风险模型进行评估。结果:在1788例边缘阳性直肠癌患者中,119例患者(6.7%)接受了IORT,而1669例患者(93.3%)接受了新辅助放疗。接受IORT的患者更年轻,更有可能有私人保险,更频繁地在学术/研究项目中接受治疗,更常见的是盆腔切除和多药化疗。倾向评分匹配后,119例IORT患者与476例新辅助RT患者进行比较。单因素分析显示,IORT与较低的死亡率相关(HR: 0.63; p)。结论:这项全国范围的分析表明,在治疗中加入IORT并不能显著提高边缘阳性直肠癌患者的总生存率。然而,由于患者选择和给药的异质性,需要进一步的前瞻性试验来阐明其临床作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The Impact of Intraoperative Radiotherapy on Margin Positive Locally Advanced Rectal Cancer: A Propensity-Matched Analysis of The National Cancer Database.

Purpose: Intraoperative radiotherapy (IORT) is utilized as an adjunctive treatment in advanced rectal cancer, particularly in cases with threatened surgical margins. Although IORT has shown benefits in enhancing local tumor control, its impact on overall survival (OS) remains unclear. This study assesses the effect of IORT on survival outcomes using a large cohort from the National Cancer Database (NCDB) and examines factors influencing its application in clinical practice across the United States.

Methods: The National Cancer Database was retrospectively reviewed (2006-2019) to identify patients with pathological T3-T4, M0 rectal cancer who underwent surgery following neoadjuvant chemotherapy. Patients with microscopically residual margin-positive were included and categorized into two groups: those who received neoadjuvant radiotherapy (RT) and those treated with intraoperative radiotherapy (IORT) combined with adjuvant/neoadjuvant RT. Groups were propensity score-matched (1:4) to balance baseline characteristics. The primary outcome was 5-year overall survival (OS), assessed using Kaplan-Meier analysis and Cox proportional hazards modeling.

Results: Among 1,788 patients with margin-positive rectal cancer, IORT was administered to 119 patients (6.7%) while 1,669 patients (93.3%) received neoadjuvant RT. Patients receiving IORT were younger, more likely to have private insurance, more frequently treated at academic/research programs, and more commonly underwent pelvic exenteration and Multiagent chemotherapy. After propensity score matching, 119 IORT patients were compared with 476 neoadjuvant RT patients. IORT was associated with lower mortality in univariate analysis (HR: 0.63; p < 0.001); however, this benefit was attenuated after adjusting for confounders (HR: 0.84; p = 0.07). The 5-year overall survival rates were 58.4% for IORT versus 54.9% for neoadjuvant RT alone (p = 0.18).

Conclusion: This nationwide analysis suggests that adding IORT to treatment does not significantly improve overall survival in margin-positive rectal cancer patients. However, due to heterogeneity in patient selection and dosing, further prospective trials are warranted to clarify its clinical role.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.70
自引率
4.00%
发文量
367
审稿时长
2 months
期刊介绍: The Journal of Surgical Oncology offers peer-reviewed, original papers in the field of surgical oncology and broadly related surgical sciences, including reports on experimental and laboratory studies. As an international journal, the editors encourage participation from leading surgeons around the world. The JSO is the representative journal for the World Federation of Surgical Oncology Societies. Publishing 16 issues in 2 volumes each year, the journal accepts Research Articles, in-depth Reviews of timely interest, Letters to the Editor, and invited Editorials. Guest Editors from the JSO Editorial Board oversee multiple special Seminars issues each year. These Seminars include multifaceted Reviews on a particular topic or current issue in surgical oncology, which are invited from experts in the field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信